NOTE M– SHARE-BASED COMPENSATION

Total share-based compensation during the

thirteen

-week periods ended

December 29, 2019

and

December 23, 2018

was

$29,000

and

$29,000,

respectively. Total share-based compensation during the

thirty-nine

week periods ended

December 29, 2019

and

December 23, 2018

was

$87,000

and

$133,000,

respectively.

Total share-based compensation is included in general and administrative expenses in our accompanying Consolidated Statements of Earnings. As of

December 29, 2019,

there was

$198,000

of unamortized compensation expense related to share-based incentive awards. We expect to recognize this expense over approximately

twenty

months, which represents the weighted average remaining requisite service periods for such awards.

The Company recognizes compensation cost for unvested stock-based incentive awards on a straight-line basis over the requisite service period. Compensation cost charged to expense under all stock-based incentive awards is as follows (in thousands):

	Thirteen weeks ended				Thirty-nine weeks ended
	December 2 9 , 201 9		December 23, 2018		December 2 9 , 201 9		December 23, 2018

Stock options	$	21	$	21	$	64	$	81
Restricted stock		8		8		23		52
Total compensation cost	$	29	$	29	$	87	$	133

Stock options:

There were

new share-based awards granted during the

thirty-nine

week period

December 29, 2019.

During the fiscal year ended

March 31, 2019,

the Company granted options to purchase

10,000

shares at an exercise price of

$89.90

per share, all of which expire

five

years from the date of grant. All such stock options vest ratably over a

three

-year period commencing

September 12, 2019.

Transactions with respect to stock options for the

thirty-nine

weeks ended

December 29, 2019

are as follows:

				Weighted-		Weighted-		Aggregate
				Average		Average		Intrinsic
				Exercise		Remaining		Value
	Shares			Price		Contractual Life		(in thousands)


Options outstanding at March 31, 2019 fiscal year (A)		42,234		$	46.807		1.32	$	1,127
Granted		-			-		-		-
Exercised		(32,234	)	$	33.438		-		1,134
Options outstanding at December 29, 2019		10,000		$	89.90		3.70		-

Options exercisable at December 29, 2019		3,333		$	89.90		3.70		-

A-

Represents outstanding options after giving effect to the replacement options issued in connection with the Company’s special dividend to shareholders of record on

December 22, 2017.

Restricted stock:

Transactions with respect to restricted stock for the

thirty-nine

weeks ended

December 29, 2019

are as follows:

				Weighted-
				Average
				Grant-date Fair value
	Shares			Per share
Unvested restricted stock at March 31, 2019		1,000		$	89.90
Granted		-			-
Vested		(333	)	$	89.90
Unvested restricted stock at December 29, 2019		667		$	89.90